0001209191-17-063045.txt : 20171130
0001209191-17-063045.hdr.sgml : 20171130
20171130170425
ACCESSION NUMBER: 0001209191-17-063045
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171129
FILED AS OF DATE: 20171130
DATE AS OF CHANGE: 20171130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAHONEY DAVID L
CENTRAL INDEX KEY: 0001224091
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36399
FILM NUMBER: 171231812
MAIL ADDRESS:
STREET 1: SYMANTEC CORPORATION
STREET 2: 20330 STEVENS CREEK BLVD.
CITY: CUPERTINO
STATE: CA
ZIP: 95014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001328143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 421560076
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-3554
MAIL ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050524
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-11-29
0
0001328143
Adamas Pharmaceuticals Inc
ADMS
0001224091
MAHONEY DAVID L
C/O ADAMAS PHARMACEUTICALS, INC.
1900 POWELL ST., SUITE 750
EMERYVILLE
CA
94608
1
0
0
0
Stock Option (Right to Buy)
35.12
2017-11-29
4
A
0
10000
0.00
A
2027-11-28
Common Stock
10000
10000
D
The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from November 29, 2017, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date.
/s/ Jennifer Rhodes, Attorney-in-fact
2017-11-30